Advanced PKPD course: February 2012, Singapore
A Workshop, presenting advanced aspects and applications of pharmacokinetics, pharmacodynamics and kinetic/dynamic data analysis in the medical and pharmaceutical sciences.
Date and Time:
Sunday, February 12, 2012 06:00 PM to Friday, February 17, 2012 12:00 PM
Hotels are expected to be full at the time of the course because the Singapore Air Show will be at the same time. It is the responsibility of participants to book their own accommodation. Please book early to make sure you have a room.
The special room rate at the Sentosa resort is only available until November 30. So book early if you want to keep your hotel costs down.
For whom intended:
The Workshop is designed for those who have a good working knowledge of basic concepts in pharmacokinetics, pharmacodynamics and data analysis and who now wish to extend their knowledge further. Emphasis will be placed on relating pharmacokinetics to underlying physiological processes and to pharmacodynamics, and on the analysis and modelling of pharmacokinetic and pharmacodynamic data.
Workshop content:
The mornings will be devoted to lectures; the afternoons to small-group workshops led by experienced tutors, in which participants will solve practical problems and develop facility with the techniques and approaches discussed in the lectures. The participants are encouraged to raise questions from their experience for discussion: time is specifically reserved for such informal discussions.
Workshop manual:
A course manual, comprising lecture outlines, derivations, problem sets with answers, and additional reading material will be provided. Participants should come with a scientific hand calculator.
Topics to be covered include:
Empirical models for pharmacokinetics and pharmacodynamics
Mechanistic models for pharmacokinetics (compartmental, physiological) and pharmacodynamics (receptor theory) and combined PKPD (immediate and delayed effects)
Data analysis techniques for empirical or mechanistic modeling: point estimates, confidence intervals, hypothesis tests.
Population pharmacokinetics and pharmacodynamics.
Disease progress and drug action modeling
Optimal design
Local host:
Dr Veronique Dartois